8-K
Current Report
CRISPR Therapeutics AG Filed Acc 0001564590-21-019504
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading crsp-8k_20210416.htm…